A detailed history of United Capital Financial Advisers, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 213,606 shares of ABT stock, worth $26.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
213,606
Previous 213,520 0.04%
Holding current value
$26.7 Million
Previous $22.2 Million 9.77%
% of portfolio
0.12%
Previous 0.19%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $8,606 - $10,159
86 Added 0.04%
213,606 $24.4 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $5.94 Million - $6.63 Million
-58,922 Reduced 21.63%
213,520 $22.2 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $2.68 Million - $2.96 Million
-24,441 Reduced 8.23%
272,442 $31 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $14.2 Million - $17.4 Million
-157,674 Reduced 34.69%
296,883 $32.7 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $2.23 Million - $2.67 Million
-23,315 Reduced 4.88%
454,557 $44 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $9.71 Million - $10.8 Million
-96,374 Reduced 16.78%
477,872 $52.1 Million
Q1 2023

Aug 14, 2023

BUY
$96.86 - $114.01 $5.17 Million - $6.09 Million
53,392 Added 11.17%
531,264 $53.8 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $2.16 Million - $2.54 Million
22,293 Added 4.04%
574,246 $58.1 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $2.03 Million - $2.38 Million
-21,337 Reduced 3.72%
551,953 $60.6 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $5.27 Million - $6.1 Million
-54,452 Reduced 8.67%
573,290 $55.5 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $9.04 Million - $10.9 Million
88,577 Added 16.43%
627,742 $68.2 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $1.95 Million - $2.38 Million
17,119 Added 3.28%
539,165 $63.8 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $153,192 - $187,575
-1,326 Reduced 0.25%
522,046 $73.5 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $2.46 Million - $2.72 Million
-21,091 Reduced 3.87%
523,372 $61.8 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $970,411 - $1.14 Million
-9,173 Reduced 1.66%
544,463 $63.1 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $1.12 Million - $1.33 Million
-10,334 Reduced 1.83%
553,636 $66.3 Million
Q4 2020

Feb 17, 2021

SELL
$105.0 - $114.42 $1.15 Million - $1.25 Million
-10,941 Reduced 1.9%
563,970 $61.7 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $1.18 Million - $1.44 Million
-12,921 Reduced 2.2%
574,911 $62.6 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $1.2 Million - $1.54 Million
-15,691 Reduced 2.6%
587,832 $53.7 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $3.81 Million - $5.57 Million
-60,648 Reduced 9.13%
603,523 $47.6 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $2.04 Million - $2.27 Million
25,958 Added 4.07%
664,171 $57.7 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $3.39 Million - $3.68 Million
-41,460 Reduced 6.1%
638,213 $53.4 Million
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $222,721 - $259,760
3,056 Added 0.45%
679,673 $57.2 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $1.09 Million - $1.32 Million
-16,518 Reduced 2.38%
676,617 $54.1 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $596,989 - $676,302
9,106 Added 1.33%
693,135 $50.1 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $65,005 - $78,421
-1,069 Reduced 0.16%
684,029 $50.2 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $7.73 Million - $8.53 Million
134,198 Added 24.36%
685,098 $41.8 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $1.7 Million - $1.92 Million
30,182 Added 5.8%
550,900 $33 Million
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $356,113 - $381,255
6,634 Added 1.29%
520,718 $29.9 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $197,718 - $220,674
4,114 Added 0.81%
514,084 $27.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
509,970
509,970 $24.8 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $219B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.